This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lifshitz Law Firm Announces Investigation Of Belo Corp., Centerline Holding Company, Invacare Corporation And StellarOne Corporation

NEW YORK, June 18, 2013 /PRNewswire/ --

Belo Corp.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Belo Corp. ("Belo") (BLC) to Gannett Co., Inc. (GCI) in a transaction valued at $13.75 per share in cash, or approximately $1.5 billion, plus the assumption of $715 million in existing debt for an enterprise value of approximately $2.2 billion.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the Belo's shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Centerline Holding Company  

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Centerline Holding Company ("Centerline") (CLNH) to Hunt Capital Partners, LLC that it or its affiliates do not already own for cash consideration of $39.89 per share.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the Centerline's shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Invacare Corporation

Lifshitz Law Firm announces that a class action suit was filed in the United States District Court for the District of New Jersey, alleging that Invacare Corporation (IVC) ("Invacare") issued false and misleading statements to investors between July 22, 2010 through December 7, 2011, inclusive by failing to adequately disclose Invacare's noncompliance with Food and Drug Administration ("FDA") guidelines and Current Good Manufacturing Practices ("CGMP"), and masked the fact that Invacare suffered from widespread operational, quality, and regulatory deficiencies.  Specifically, Invacare concealed from investors that it received a series of warnings from the FDA -- known as Forms 483 -- which identified serious compliance violations at its two major United States-based manufacturing facilities.  The firm is investigating legal claims against the officers and Board of Directors of Invacare.

For more information, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

StellarOne Corporation

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of StellarOne Corporation ("StellarOne") (STEL) to Union First Market Bankshares Corporation ("Union") in a transaction with an implied a deal value per share of $19.50 or approximately $445.1 million in the aggregate based on Union's closing stock price of $20.02 on June 7, 2013.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the StellarOne's shareholders.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs